C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation is a research paper published in mBio (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: 1R01AI155723
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: 1R15AI142699
HHS | NIH | National Center for Research Resources
Grant: 5 P41 RR001209
NIAID NIH HHS
Grant: R15 AI142699
NCRR NIH HHS
Grant: P41 RR001209
NIAID NIH HHS
Grant: R01 AI155723
NIAID NIH HHS
Grant: R01 AI174599
National Institutes of Health
Grant: 5P41RR001209-14
A SYNCHROTRON RADIATION BIOTECHNOLOGY RESOURCE
National Institutes of Health
Grant: 1R15AI142699-01
Antibiotics Designed to Counter Resistant 21st Century Pathogens
National Institutes of Health
Grant: 5R01AI155723-05
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
FWCI
0.92
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals